Marvell Technology, Inc.

Marvell Technology’s stock ride since 2016 would have turned a $1,000 bet into about $22,400 by Oct. 2026, as the company moved from hard-drive storage chips to AI data-center infrastructure. Hyperscalers building AI clusters propelled data-center revenue to $2.17 billion last quarter, 79% of total, with fiscal 2026 revenue up 42% to $8.19 billion. Management exited the auto Ethernet business for $2.5 billion in 2025 and bought Celestial AI and XConn Technologies in 2026, while expanding a custom-chip deal with Alphabet/Google that includes a revenue-based warrant. The stock endured three brutal declines (37%–57%), yet long-term holders captured most gains; traders who sold on dips missed much of the upside. Bulls see revenue accelerating to about $12 billion in fiscal 2027, with double-digit growth into 2028; bears flag rich valuations and customer concentration risk, plus debt and China trade limits.

Marvell Technology schedules Investor Day for Oct. 6 to outline its AI/data-center strategy. CEO Matt Murphy will explain how custom silicon, AI connectivity, and data-center products drive growth and how today’s AI demand translates into expansion. The company has raised guidance for fiscal 2027 and 2028. In Q2 FY2027, revenue rose 37% to $2.7 billion, with data-center revenue up 46% to $2.17 billion. Management projects Q3 revenue around $3.15 billion and lifts FY2027 revenue to about $12 billion, with FY2028 near $18 billion and data-center growth above 60%. Investor Day will assess how much growth comes from custom silicon, connectivity, and switching, plus the longer-term custom opportunity. CFO has discussed a potential $10B+ custom business by 2029. Partnerships with Google (custom AI accelerators; Google holds a warrant for up to ~59 million shares) and Nvidia broaden the addressable market. Street calls Strong Buy with upside to roughly $400.

Marvell Technology reported Q2 adjusted net income of $865.9 million vs. $308 million GAAP, highlighting how non-GAAP gains can mask cash reality. Revenue was $2.74 billion, up 37%, with data-center revenue up 46%; GAAP gross margin was 53.1% vs. 58.9% on an adjusted basis. Backing out amortization and stock compensation, while acquisition-related amortization is noncash, shows substantial capital needs and dilution risks. Marvell’s shares outstanding were about 876.9 million, with short interest near 3.6% of float. Operating cash flow was $605.5 million, lagging the adjusted net income and raising cash-conversion questions. At a $231.7 billion market cap, sustainable free cash flow of $5–10 billion would require meaningful growth and likely more dilution. The piece weighs bullish programs against ongoing capital needs, arguing value hinges on retained cash per share.

Marvell Technology sprinted from about $85 at the start of 2026 to roughly $263, and growth is accelerating. In fiscal Q2 2027, revenue rose 37% year over year to $2.74 billion, with data-center revenue up 46%; management guided for about $3.15 billion in the current quarter, implying more than 50% growth. Non-GAAP EPS was $0.94 and adjusted margin reached 36.6%, with a target to 38%-40% in Q4. Growth is led by two pillars: custom AI chips for a cloud customer and optical connectivity for AI servers. Google, a unit of Alphabet, holds a warrant to buy up to about 59 million shares, vesting as Google buys custom chips through 2033, potentially up to $120 billion in purchases. At ~39x fiscal 2028 earnings, the stock could reach around $527 by end-2031 if earnings compound ~15% annually; risks include lower margins on custom chips and possible AI spending slowdown. An Oct. 6 investor day may set longer-term targets.

Marvell Technology's data-center push gains steam as hyperscalers adopt its custom AI silicon. After a 36% quarterly revenue rise, Marvell lifted its fiscal 2028 revenue outlook to about $18 billion, with custom silicon revenue expected to more than double. The company cites more than 20 design wins across Amazon, Alphabet/Google, Microsoft, and Meta, and the Alphabet deal could be the most impactful: roughly $120 billion in cumulative revenue over six years if milestones are met. Management expects revenue to accelerate in the second half of the year and for custom silicon to drive notable growth in fiscal 2028–29, while non-custom products should benefit from demand tied to Google's TPUs and other hyperscalers. Risks include dependence on Taiwan Semiconductor and other Asian suppliers, execution pace, margins, and broader data-center cycles. Valuation remains lofty, but meeting long-term targets could unlock meaningful upside at Investor Day on Oct. 6, 2026.

Marvell Technology unveiled demonstrations of 2nm optical interconnects at ECOC 2026 and expanded its IC-substrate supply with AT&S to support future AI and cloud infrastructure products. The 2nm optics target AI networking and cloud-data-center connectivity, part of a strategy to grow hyperscaler share toward 20% of a data-center market expected around US$94 billion by 2028. The AT&S deal aims to secure capacity and mitigate supply-chain risk for advanced substrates. While these demos signal progress, sustained data-center revenue growth and stable margins through fiscal 2027 will determine their impact, especially given Marvell already derives about 74% of revenue from data-center customers. The piece casts these catalysts as part of a broader AI-infrastructure build-out that investors are watching.

Marvell Technology is poised for a potential upside at its Oct. 6 Investor Day as demand for its custom AI processors and networking chips grows. Counterpoint Research expects AI processor shipments to triple from 2024–2027, and Goldman Sachs highlights networking as a key AI-infrastructure bottleneck. Marvell has repeatedly raised guidance, lifting fiscal 2027 revenue to $12 billion and fiscal 2028 to $18 billion. RBC Capital Markets anticipates a further uplift at the investor day, projecting higher 2029 AI revenue by at least $2 billion and expanded TAM and 2030 market-share estimates. The firm’s earnings trajectory could accelerate toward sustained margins, with long-run EPS targets cited around $15–$20. Despite a pullback from 52-week highs, the stock’s upside hinges on management’s updated forecasts and the ensuing investor sentiment.

Marvell Technology is labeled an AI infrastructure play outside Nvidia. A 24/7 Wall St. Buy rating comes with a $285 target (about 8% above current $263). The stock is up roughly 206% year to date, as management guides fiscal 2027 revenue near $12B and projects data-center revenue rising 60%+ in fiscal 2028. In Q2, Marvell revenue was $2.739B (up 36.6%), non-GAAP EPS $0.94, and data-center sales of about $2.17B (79% of revenue). Google expanded its custom-silicon deal with Marvell, including a warrant to acquire up to 7% of shares if revenue targets are met. Valuation remains rich: forward P/E around 62x vs Broadcom ~19x, and sentiment is overwhelmingly bullish with about 39 Buy/Strong Buy ratings and no Sells. A bull scenario targets $353.98; risks include customer concentration, China limits, supply constraints, and rising debt.

Marvell Technology posted 37% YoY sales growth in fiscal Q2 2027 and raised guidance for FY2027 and FY2028. Data-center customers, led by a single large buyer, accounted for about 79% of revenue, with data-center sales up 46% YoY and management forecasting roughly 60% data-center growth for FY2027. The company plans about $1 billion in capacity prepayments for FY2027 as it expands capacity, and shares trade near 91x TTM earnings, well above the S&P 500. Full-year guidance targets about $18 billion in revenue for FY2028. A potential risk is a pause or cut in AI spending by major data-center customers, despite management affirmations. OpenAI reportedly paused training its latest models in Sept 2026, though spending guidance remains optimistic. Investor Day on Oct 6 will test whether the FY2028 target holds; Q3 guided midpoint revenue is $3.15B, above Q2's $2.74B.

Broadcom beat prior expectations in Q3 FY2026 with non-GAAP EPS of $3.32, up 96% YoY, and revenue of $29.59 billion, up 85.5%. AI semiconductors dominated growth, delivering $16.7 billion in AI revenue (56% of total) as XPU shipments surged over 3.5x and AI networking grew more than 2.5x. Semiconductors revenue hit a record $20.84 billion, with margins improving: non-GAAP gross margin 75% and operating margin 67.9%. Free cash flow was a record $13.67 billion; cash and equivalents $24 billion; dividends paid $3.1 billion; debt reduced by $5.6 billion. Q4 guidance calls for about $34.8 billion in revenue, with AI-driven growth continuing and gross margin around 73%, non-GAAP operating margin ~66%. Broadcom raised its AI revenue outlook to $58 billion for FY2026, with longer-term targets of $115 billion (2027) and $230 billion (2028). The piece also notes MRVL’s gains over the past month and MRVL quarter results.

Vera Rubin is NVIDIA’s next AI data-center system after Blackwell. Production shipments began in August 2026, and management expects Vera Rubin to account for about 20% of data-center revenue in fiscal Q3 2027, a large share for a product only weeks into launch. Independent confirmations show early real-world use: Supermicro is shipping racks built on Vera Rubin, and CoreWeave reports a customer running production workloads on the system by late September. Management estimates Vera Rubin could unlock roughly $40 billion in revenue per gigawatt of data-center capacity, a higher opportunity than Blackwell. The company still faces supply constraints and rising memory costs; gross margin is seen at about 74% in Q3 2027, dipping to 71-72% in Q4 and stabilizing near 72-73% in 2028 as price effects take hold. NVIDIA’s Q3 2027 results are due around November 17, 2026.

Marvell Technology generated 79% of fiscal Q2 2027 revenue from data centers, with data-center revenue of $2.17B, up 46% YoY. A Sept. 28, 2026 report linked AI-stock declines to OpenAI halting training; MRVL has more than tripled in the last year, but an AI-demand slowdown could hit growth first in data-center sales. At about 25.1x trailing sales, the stock prices revenue not yet delivered. Management guided fiscal 2028 revenue to about $18B (vs ~$12B in fiscal 2027) and expects data-center revenue to grow more than 60% in 2028. If AI demand slows and the latest quarter repeats, annual revenue could approach $11B, with roughly $1.2B in profit—a very rich multiple. Free cash flow in the past twelve months was $1.7B; net debt about $1.0B, suggesting cushion for a slowdown. Investor Day on Oct 6 will indicate whether a slowdown is coming and how the valuation holds up.

Marvell Technology's Data Center segment remains the engine, now about 79% of revenue after $2.739 billion in the last quarter, a 46% year-over-year increase. Data Center revenue hit $2.17 billion, and total revenue surpassed estimates as management raised guidance. Third-quarter revenue is guided to $3.15 billion, implying more than 50% growth at the midpoint, with Data Center growth near 75%. Alphabet expanded its custom silicon arrangement with Marvell, including a warrant for up to 7% of MRVL tied to revenue milestones, diluting equity if targets are hit. The company projects fiscal 2027 revenue near $12 billion and FY2028 growth about 50%, with the custom business seen more than doubling in 2028. Analysts have raised estimates; valuation remains elevated with a forward P/E around 62x. Investor Day and margin progress to the 38–40% range are key catalysts; sector AI softness remains a risk.

Marvell Technology affirmed a quarterly dividend of $0.06 per share while highlighting a robust AI infrastructure growth trajectory. The stock jumped about 27% in the past month and ~200% year-to-date, with a 1-year total shareholder return near 212%. The market weighs new AI data-center wins against an already rich valuation. Valuation views diverge: Simply Wall St. pegs fair value at about $140 and calls the stock overvalued, while a DCF-based estimate around $280 suggests only a modest gap at current levels. The piece notes Nvidia’s $2 billion investment and ongoing Google conversations as signs of conviction, but cautions risks if hyperscaler capex slows or Amazon increases competition. It encourages comparing MRVL to a broader AI infrastructure universe and using screens for potential opportunities, while warning that near-term upside may depend on execution and demand momentum.

NVIDIA stock is described as more volatile and more market-correlated than the S&P 500. On typical down days the index fell 0.61% while NVIDIA declined 1.08%; on up days the index rose 0.64% and NVIDIA climbed 1.15%. One-year volatility sits at 37.7% for NVIDIA versus 13.0% for the index, and beta runs about 1.89. Over five years, NVIDIA’s total return is about 61.8% per year versus 13.5% for the S&P. The piece notes that NVIDIA’s swings follow AI-data-center spending, which accounted for $89 billion of its $96 billion quarterly revenue and is expected to grow roughly 70% in fiscal 2028, constrained by supply. The company also uses balance-sheet financing with AI labs and warns that those dynamics may alter investor sentiment toward AI suppliers. The article ends by contrasting this risk with a diversified HQ Portfolio.

AI infrastructure spending is moving from buying accelerators to wiring large clusters, boosting connectivity suppliers. Credo (CRDO) is highlighted as the fastest-growing among peers, with Q1 revenue up about 115% to $479 million and non-GAAP EPS of $1.20, while two customers account for roughly 61% of revenue. The stock trades around 27x forward earnings, well below Astera Labs (56x) and Marvell (62x) despite faster revenue growth. Bulls see upside to about $242 with potential bull-case targets above $330, while a bear scenario warns of hyperscaler softness or a top customer switching suppliers. Credo’s OmniConnect memory-connectivity line could add meaningful revenue from fiscal 2028, alongside growing optical DSPs and silicon photonics. Relative to peers, Credo’s growth appears to justify a lower multiple, keeping risk/reward favorable but concentrated.

Marvell Technology (MRVL) has been a top search on Zacks, with the stock up about 28% in the last month and the broader Electronics – Semiconductors group up 7.4%. The rally is framed by favorable earnings-estimate revisions: higher projected earnings boost the stock's fair value and can lift prices. For the current quarter, MRVL is expected to earn $1.10 per share, up 44.7% year over year, with the consensus estimate rising slightly. Full-year EPS are seen at $4.21 (+48.2%), and next year at $6.74 (+60%), with recent estimates up about 1.8%. Revenue guidance sits at $3.16 billion for the current quarter (+52.1% YoY), and about $12.0 billion and $18.03 billion for this year and next. Last quarter delivered $2.74 billion in revenue and $0.94 EPS, beating expectations. Zacks assigns a Hold (Rank 3); near-term movement may track the broad market.

AMD stock jumped 9.9% on Sep 21, 2026, after reports the company plans a 10% fourth‑quarter price increase to offset higher wafer costs. A price rise can lift profit only if costs don’t rise as much; AMD’s gross margin has climbed to about 53% over the last 12 months, with management guiding roughly 56% for Q3. No figures yet on how much of the price lift remains after wafer costs. The stock trades at about 155 times trailing earnings, far above the S&P 500. AMD’s data‑center business dominated, about 58% of Q2 revenue, and management expects data‑center revenue to more than double in 2027. If the price increase goes through, the adjusted gross margin for Q4 could rise above Q3 guidance. The forecast for data‑center growth remains intact, and some investors may seek diversified exposure like the HQ Portfolio.

Credo Technology Group Holdings reported Q1 fiscal 2027 revenue of $479 million, up 114.7% YoY and 9.6% sequential, the seventh straight quarter of triple-digit growth. Revenue remains AI-infrastructure focused, with the top four customers totaling at least 10% each and the largest at 33%. AECs remain the largest unit, aided by hyperscale adoption; the shift to 200G-per-lane 1.6T ports adds another growth vector. Optical revenues expanded across DSPs, silicon photonics PICs and ZeroFlap optics, with DustPhotonics revenues ramping and 800G/1.6T opportunities ahead. Non-GAAP gross margin was 68% (GAAP 64.5%), and non-GAAP operating income was $230.6 million. Free cash flow was $82.9 million; cash and short-term investments stood at $764.3 million after DustPhotonics. Q2 guidance is $525–$535 million; full-year 2027 revenue growth is expected above 85%.

NVIDIA rose 17.2% over three months, beating the 5.8% sector gain and outpacing peers including Marvell Technology (MRVL), which rose 7.7%. AI demand and strong results underpin the rally. Q2 revenue jumped 106% year over year to $96.22 billion, with Data Center revenues up 117% to $89.02 billion. Non-GAAP gross margin was 75%; non-GAAP net income rose 118% to $53.95 billion (EPS $2.22). The company guided third-quarter revenue near $108 billion. Growth is widening beyond GPUs to CPUs, networking and full AI-infrastructure systems, aided by Vera Rubin and Blackwell. Cash flow remained robust ($24.08B operating, $21.34B free) with buybacks around $25.8B and an extra $150B authorization. Forward P/E about 17.18; NVIDIA remains a leadership stock. Buy NVDA; MRVL is a peer.

Marvell has shifted from a broader recovery story outside the data center to focusing on data-center growth. It shrank and sold off non-data-center markets (including auto), regrouping the remaining businesses under 'communications and other' before pivoting back to data center emphasis. Data center revenue rose to $2.17B in Q2 FY2027, about 79% of total, while non-data-center sales totaled $568M. Management now guides ~60% data-center revenue growth for FY2027 (up from ~50%), with the custom AI silicon ramp expected in H2 and possibly doubling in FY2028. Outside markets are still growing but far slower and smaller, raising concentration risk if data-center demand slows. Investor Day on Oct 6 will outline longer-term growth; Q3 FY2027 revenue guidance is $3.15B +/-5%.

Cerebras Systems sells AI hardware and rents compute via its cloud. The stock trades about 37% below its 52-week high despite a raised 2026 revenue forecast, but the company remains loss-making. Remaining performance obligations reached $25.4 billion as of 6/30/2026—contracts signed but not yet delivered. Core revenue guidance for 2026 is $880–$890 million; Q2 2026 core revenue was $209.9 million, up 103% year over year, led by its cloud deployment and growing OpenAI usage. The 2027 target is for core revenue to more than triple. Valuation sits around 51x sales, reflecting steep growth expectations. Signed work excludes AWS and other hyperscalers; AWS Bedrock should be generally available in 1Q 2027. Cerebras has secured over 600 MW of data-center capacity by end-2027 and rents capacity today to meet demand, pressuring short-term gross margins. OpenAI’s share is expected to shrink but stay meaningful in 2027. Third-quarter results will show if signed work turns into sales; space constraints could hinder 2027 growth.

Cerebras Systems (CBRS) sells AI hardware and rents cloud compute. The stock sits about 37% below its 52-week high after management raised 2026 core-revenue guidance to $880–$890 million; Q2 core revenue was $209.9 million, up 103% YoY, led by cloud usage as OpenAI deployments ramp. Management targets core revenue to more than triple in 2027. As of June 30, 2026, Cerebras reported $25.4 billion in remaining performance obligations, signed work not yet delivered, indicating substantial future sales. No AWS or other hyperscaler deals are signed yet; AWS Bedrock should be generally available in 1Q2027, potentially adding to signed work. Data-center space is the bottleneck; Cerebras has secured 600+ MW of capacity and rents capacity to meet demand, weighing on near-term gross margins. OpenAI's share is expected to shrink but remain meaningful in 2027. Q3 results will reveal how quickly signed work converts to revenue and whether space limits the 2027 plan.

Marvell Technology trades at about $263 and a roughly $231 billion market cap, valued at about 80x trailing adjusted earnings, with analysts forecasting fiscal 2027 earnings of about $3.9B and fiscal 2028 of $6.2B. The implied 2028 price assumes 51% revenue growth to roughly $18.2B and a net margin rising to about 34% by 2028, with management targeting 38–40% adjusted operating margin by late fiscal 2027. Risks include a potential gross-margin dip during the Q3 2027 ramp for its custom business, uncertainty around custom sales doubling in 2028, and the possibility that operating spend drifts with or faster than sales; supply constraints could push capacity late and trim the forecast. If Marvell hits the 2028 forecast, the 2028 multiple is fair; if margins don’t widen, the stock could be riskier.

AMD guided Q3 revenue to about $13 billion, up from $11.2 billion, led by double-digit growth in data center and embedded segments with a modest decline in client and gaming and a softer PC market in H2 2026. Adjusted gross margin is planned around 56%. The chart shows an intact uptrend, though shares briefly fell after the earnings release before rallying again as management hit or exceeded guidance. Helios AI platform shipments are expected later in Q3, and management anticipates data-center revenue to more than double in 2027, despite ongoing supply constraints. With the stock trading at a rich multiple, a strong Q3 result toward the top of guidance could extend gains, while a miss could undermine the rally.

Rambus (RMBS) posted fiscal Q2 revenue of $207.38M, with record product revenue of $99.15M and non-GAAP EPS of $0.77, while signaling an exciting Tier-1 US hyperscaler win for next-gen HBM in future AI chips. Management sees silicon IP growth of 10%–15% annually, aided by DDR5 and MRDIMM ramps, with PCIe IP coming in. 24/7 Wall St. sets a $132.68 price target (about 26% upside) and a bull case of $178.44. Rambus trades around 30x forward earnings, versus Micron at ~7x and Marvell at ~62x; the stock sits roughly 42% below its 52-week high of $174.10. Risks include supply constraints delaying MRDIMM ramps beyond 2027 and potential weakness in Q3 product revenue guidance ($110–$116M). Rambus is positioned as a key AI-infrastructure supplier amid rising hyperscaler demand.

Marvell Technology’s stock jumped about 5% on Tuesday after Citigroup issued a bullish note ahead of the company’s investor day on Oct. 6. Citi analyst Atif Malik reiterated a Buy rating and a $275 price target, arguing AI data-center infrastructure opportunities justify the optimism. Malik noted management has raised revenue guidance for fiscal 2027 and 2028, with the 2028 figure poised to grow roughly 50%. The surge reflects steady demand for Marvell’s silicon in AI deployments and a more favorable long‑term outlook, even as near‑term outcomes depend on execution and AI spending cycles.

Marvell Technology's stock rose about 4.7% after Citi reiterated a Buy rating with a $275 target ahead of its Oct. 6 Investor Day, citing AI data-center networking opportunities. Citi lifts fiscal 2027 and 2028 revenue targets to roughly $12B and $18B, with potential 2030 earnings of $15–$20 per share, and notes a custom revenue target above $10B for fiscal 2029 from a Google deal plus about $300M in scale-up optics sales. The shares later cooled to about $261.81, up ~3.9% from the prior close. MRVL has been highly volatile (62 moves >5% in a year). Broader market factors—OpenAI pausing frontier-model training, rising Brent crude, and higher yields—could pressure semiconductor multiples if hardware demand slows, though MRVL is up ~193% year-to-date and still ~17% below its 52-week high.

GLOBALFOUNDRIES (GFS) rose 34.1% in the last year, trading around $47.86 as investors weigh its cash-generating potential. A DCF assessment indicates intrinsic value well below the current price, even as the market prices in long-term growth. Newly finalized CHIPS R&D support of $375 million and an expanded SiGe production deal with Marvell could shift investment needs and the timing of cash inflows from quantum tech and data-center demand. Analysts model higher cash flows into the early 2030s, reflecting maturity of the business, while market narratives claim the stock is undervalued by roughly 37%. The analysis emphasizes that shares may be supported by expectations beyond the DCF horizon, and cautions that the numbers do not constitute financial advice.

Marvel Biosciences Corp. closed its non-brokered private placement, issuing 10,654,298 units at $0.15 for about $1.60 million. Each unit includes one common share and one warrant exercisable at $0.20 for one year; warrants may be accelerated if the TSXV VWAP reaches $0.25 for five consecutive trading days, with notice and no earlier than 30 days after closing. Finders were paid about $77,175 in cash and 494,737 Finder’s Warrants to several brokers (Raymond James, Canaccord, Research Capital, Acumen, Hampton, Leede). Net proceeds fund a deposit for Phase 1 MB-204 trials, plus G&A and working capital. An offering document dated Sept. 16, 2026 is available on SEDAR+ and Marvel's site under NI 45-106; units are not subject to a Canadian hold period. MB-204 is a fluorinated derivative of Istradefylline targeting adenosine A2a receptors for neurological and related indications, using a drug redevelopment model.